![Table 5 from Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial. | Semantic Scholar Table 5 from Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2541c720866d0f7409f45328b7e39afe211e66a0/5-Table5-1.png)
Table 5 from Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial. | Semantic Scholar
![PDF] Comparison between Calcitriol and Calcitriol Plus Low-Dose Cinacalcet for the Treatment of Moderate to Severe Secondary Hyperparathyroidism in Chronic Dialysis Patients | Semantic Scholar PDF] Comparison between Calcitriol and Calcitriol Plus Low-Dose Cinacalcet for the Treatment of Moderate to Severe Secondary Hyperparathyroidism in Chronic Dialysis Patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cb34a81e16277c6a70dc635cf9d1a769b1c3f1dd/11-Figure2-1.png)
PDF] Comparison between Calcitriol and Calcitriol Plus Low-Dose Cinacalcet for the Treatment of Moderate to Severe Secondary Hyperparathyroidism in Chronic Dialysis Patients | Semantic Scholar
![Biomedicines | Free Full-Text | Association of Calcitriol Supplementation with Reduced COVID-19 Mortality in Patients with Chronic Kidney Disease: A Population-Based Study Biomedicines | Free Full-Text | Association of Calcitriol Supplementation with Reduced COVID-19 Mortality in Patients with Chronic Kidney Disease: A Population-Based Study](https://www.mdpi.com/biomedicines/biomedicines-09-00509/article_deploy/html/images/biomedicines-09-00509-g003-550.jpg)